Printer Friendly

Deal snapshot: ZALGEN LABS LAUNCHES VIRAL DIAGNOSTICS BUSINESS FOLLOWING TRANSFER FROM CORGENIX MEDICAL.

MANews-(C)2009-2016

US-based biotechnology and diagnostics company Zalgen Labs has received via transfer the viral hemorrhagic fever diagnostics business from diagnostic test kit developer Corgenix Medical Corp. and opened an advanced product development centre in the Fitzsimons Bioscience Park Center on the University of Colorado Anschutz Medical Campus in Aurora, Colorado, the company said.

In November 2013, Corgenix Medical and Zalgen Labs entered into a collaboration agreement to the development of multiple diagnostic testing platforms and immunotherapeutics for high impact neglected infectious diseases.

Country: USA

Sector: Biotechnology

Target: Corgenix Medical/viral hemorrhagic fever diagnostics business

Buyer: Zalgen Labs

Vendor: Corgenix Medical Corp

Deal size in USD:

Type: JV

Financing:

Status: Closed

Buyer advisor: , ,

Comment: Part of deal hatched in 2013

COPYRIGHT 2016 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M & A Navigator
Date:Aug 23, 2016
Words:121
Previous Article:UK Competition and Markets Authority Publishes Decision on Hammerson's Acquisition of Birmingham Shopping Centre.
Next Article:Deal snapshot: WESBANCO RECEIVES REGULATORY APPROVALS FOR USD 221M YOUR COMMUNITY ACQUISITION.
Topics:

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters